Interaction between cyclosporin A and nonsteroidal antiinflammatory drugs

Journal of Rheumatology

Volumn 24, Issue 6, 1997, Pages 1122-1125

  Tugwell, Peter ^a,d   Ludwin, David ^b   Gent, Michael ^b   Roberts, Rob ^b   Bensen, William ^b   Grace, Eileen ^b   Baker, Philip ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Clinical epidemiology; Combination therapy; Crossover study; Cyclosporin A; Drug interaction; Glomerular filtration

Indexed keywords

CYCLOSPORIN A; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SULINDAC;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG COMBINATION; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COMBINED MODALITY THERAPY; CREATININE; CROSS-OVER STUDIES; CYCLOSPORINE; DRUG INTERACTIONS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INDOMETHACIN; KETOPROFEN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0030996781     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tugwell P, Bombardier C, Gent M, et al: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990;335:1051-5.
2. Yocum DE, Klippel JH, Wilder RL, et al: Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study. Ann Intern Med 1988;109:863-9.
3. Dougados M, Duchesne L, Awada H, Amor B: Assessment of efficacy and acceptability of low-dose cyclosporin in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:550-6.
4. Dougados M, Duchesne L, Awada H, Amor B: Assessment of efficacy and acceptability of low-dose cyclosporin in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:550-6.
5. Wells G, Tugwell P: Cyclosporin A in rheumatoid arthritis: Overview of efficacy. Br J Rheumatol 1993;32:51-6.
6. Arnett FC, Edworthy SE, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
7. Cockcroft DW, Gault HH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
8. Klinkhoff AV, Bellamy N, Bombardier C, et al: An experiment in reducing inter-observer variability of the examination for joint tenderness. J Rheumatol 1988;15:492-4.
9. Huskinsson EC: Measurement of pain. J Rheumatol 1982;9:763-9.
10. Skorecki KL, Rutledge WP, Schrier RW: Acute cyclosporin nephrotoxicity: Protype for a renal membrane signalling disorder. Kidney Int 1992;42:1-10.
11. Hannedouche TP, Delegado AG, Gnionsahe AD, Boitard C, Noel LH, Grunfeld JP: Nephrotoxicity of cyclosporin in autoimmune diseases. Adv Nephrol 1990;19:169-86.
12. Richards NT, Poston L, Hilton PJ: Cyclosporin A inhibits endothelium-dependent, prostanoid-induced relaxation in human subcutaneous resistance vessels. J Hypertens 1990;8:159-63.
13. Weinblatt M, Helfgott S, Coblyn J, et al: The effects of cyclosporin A on eicosanoid excretion in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:481-5.
14. Tegzess AM, Doorendos BM. Minderhoud JM, Donker AJM: Prospective serial renal function studies in patients with non-renal disease treated with cyclosporin A. Transplantation Proc 1988;(suppl 3)20:530-3.
15. Berg KJ, Forre O, Djoseland O, Mikkelsen M, Narveurd J, Rugstad HE: Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis. Clin Nephrol 1989;31:232-8.
16. Ludwin D, Bennett KJ, Buchanan WW, Bensen W, Bombardier C, Tugwell P: Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporin. Transplantation Proc 1988;20:367-70.
17. Sandler DP, Burr FR, Weinberg CR: Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1990;112:568-76.
18. Whelton A, Stout RL, Spilman PS, Klassen DK: Renal effects of ibuprofen, piroxicam and sulindac in patients with asymptomatic renal failure. A prospective, randomized, crossover comparison. Ann Intern Med 1990;112:568-76.
19. Eriksson LO, Sturfelt G, Thysell H, Wolheim FA: Effects of sulindac and naproxen on prostaglandin excretion in patients with impaired renal function and rheumatoid arthritis. Am J Med 1990;89:313-21.
20. Altman RD, Perez GO, Sfakianakis GN: Interaction of cyclosporin A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis (abstr). Arthritis Rheum 1991;(suppl)34:S93.
21. Forre O, Bjerkhoel F, Salvesem CF: An open controlled randomized comparison of cyclosporin and azathioprine in the treatment of rheumatoid arthritis: A preliminary report. Arthritis Rheum 1987;30:88-92.
22. Bradley J: Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91.
23. The Cooperative Clinics Committee of the American Rheumatism Association. A seven-day variability study of 499 patients with peripheral rheumatoid arthritis. Arthritis Rheum 1965;8:302-35.
24. Guyatt GH, Sackett D, Taylor DW: Determining optimal therapy: Randomized trials in individual patients. N Engl J Med 1986;314:889-92.
25. Panayi GS, Tugwell P: The use of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 1993;32:1-3.